APIs are the core elements responsible for the intended physiological effects of pharmaceutical drugs. They are produced through meticulous processing of chemical compounds. In biologic drugs, the active ingredient is referred to as a bulk process intermediate (BPI). Despite the associated manufacturing costs, stringent regulations, and pricing control policies, the API market presents attractive opportunities due to the escalating prevalence of chronic diseases such as diabetes, asthma, and cancer.

APIs can be broadly categorized into two types: synthetic and natural. Synthetic APIs are further classified as innovative or generic, depending on the synthesis methods employed.

Synthetic chemical APIs, also known as small molecules, comprise a significant portion of the pharmaceutical market, with numerous small-molecule drugs commercially available.

On the other hand, natural APIs are employed in the production of biologics, which have gained prominence as top-selling drugs, although their numbers remain relatively fewer compared to small molecule drugs.

APIs can also be classified as insoluble or soluble based on their solubility characteristics.

APIs and intermediates form the backbone of the pharmaceutical industry, enabling the development of effective and life-saving medications. The market for APIs is propelled by the rising prevalence of chronic diseases. Understanding the various types of APIs and their sources is crucial for pharmaceutical professionals involved in manufacturing, research, and procurement.

Tosun Pharm is one of the top active pharmaceutical ingredients and intermediates suppliers in China. For more information on APIs and intermediates, contact us today.